## BACKGROUND. Because malignant transformation of dysplastic oral leukoplakia has been reported in up to 43% of cases, these lesions must be managed. ## METHODS. This study evaluated the use of topical 1% bleomycin in dimethylsulfoxide for the treatment of dysplastic oral lesions. Bleomycin wa
Treatment of oral leukoplakia with topical bleomycin. A pilot study
โ Scribed by F. Wong; J. Epstein; A. Millner
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 538 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract __Background.__ Oral leukoplakia and oral erythroplakia may be associated with benign and dysplastic cellular changes, and are at risk of malignant transformation. Additional means of management of these lesions is needed. The results of nonblinded trials using topical bleomycin in oral
## Background and objectives: Our recent studies showed that a new topical 5-aminolevulinic acid-mediated photodynamic therapy (ala-pdt) protocol using a light-emitting diode (led) light source is an effective and successful treatment modality for five cases of oral verrucous hyperplasia (ovh) and
Our studies in human epidermal keratinocytes as a model system have suggested that the antibiotic topoisomerase II inhibitors, novobiocin and nalidixic acid, may be of value for the treatment of hyperproliferative skin disorders. We have therefore conducted a pilot study of the clinical efficacy of